The first inhalable vaccine for measles is moving toward clinical trials next year in India, where the disease still sickens millions of infants and children and kills almost 200,000 annually, according to researchers. The dry-powder vaccine is a perfect fit for use in back-roads areas of developing countries that may lack access to electricity and needles, the scientists say.